Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CGEMY | NRG |
|---|---|---|
| Price | $24.35 | $96.80 |
| Change today | ▼ 0.73% | ▲ 1.65% |
| Market cap | $20.36B | $20.35B |
| Return, 3 months | +14.4% | -29.6% |
| Return, year to date | -24.3% | -38.6% |
| Return, 1 year | -13.9% | -40.2% |
| P/E (TTM) | 13.2 | 25.2 |
| P/B | 1.6 | 4.8 |
| P/E percentile vs own 5y | – | 77th |
| Dividend yield | 3.24% | 1.89% |
| Revenue growth (YoY, latest qtr) | – | +11.0% |
| Net profit growth (YoY) | – | +586.5% |
| Gross margin | – | 18.8% |
| Operating margin | – | 6.3% |
| Net margin | – | 2.4% |
| Return on equity | – | 26.8% |
| Analyst target vs. price | – | +105.4% |
| Analyst buy share | – | 82% |
| RSI (14) | 51 | 35 |
| 30-day volatility | 43.3% | 36.8% |
| Max drawdown, 1 year | -43.4% | -47.9% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
